Position in VRTX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$377,514
+$38,144 QoQ
Shares Held
760
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.27%
of 13F equity value
Holder Rank
#1,158
of 1,735 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Symmetry Inc holds $378,217 across 2 Biotechnology names. VRTX ranks #1 (99.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
760 | $377,514 | |
| 2 | PVCT |
Provectus Biopharmaceuticals, Inc.
|
10,191 | $703 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $377,514 | 760 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $339,370 | 760 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $342,286 | 755 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $295,688 | 755 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $336,126 | 755 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $366,039 | 755 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $304,038 | 755 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $351,135 | 755 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $353,883 | 755 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $315,597 | 755 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $307,201 | 755 | Shares | Sole | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||